A three-factor model of the madrs in Major Depressive Disorder

被引:67
作者
Suzuki, A [1 ]
Aoshima, T
Fukasawa, T
Yoshida, K
Higuchi, H
Shimizu, T
Otani, K
机构
[1] Yamagata Univ, Sch Med, Dept Psychiat, Yamagata 9909585, Japan
[2] Akita Univ, Sch Med, Sch Psychiat, Akita 010, Japan
关键词
Major Depressive Disorder; MADRS; factor analysis;
D O I
10.1002/da.20058
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Major Depressive Disorder (MDD) may be composed of some symptom clusters with distinct neurochemical disturbances, suggesting the importance of the factor analysis of depressive symptoms; however, the results of previous studies using the Montgomery-Asberg Depression Rating Scale (MADRS) have been inconsistent In the present study, factor analysis of the MADRS was performed in 132 Japanese patients (range 23-74 years, mean 47.6 years) with MDD without any psychiatric comorbidity. The principal component analysis with Varimax rotation identified three factors, accounting for 61% of the total variance: The first factor, labeled dysphoria, included pessimistic thoughts, suicidal thoughts, and reported sadness; the second factor, labeled retardation, included lassitude, inability to feel, apparent sadness, and concentration difficulties; and the third factor, labeled vegetative symptoms, included reduced sleep, reduced appetite, and inner tension. The score of the vegetative factor showed a significant positive correlation with age and was significantly higher in females than in males. This study suggests that the symptoms of MDD, as assessed by the MADRS, cluster into three factors (dysphoria, retardation, and vegetative symptoms). (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:95 / 97
页数:3
相关论文
共 24 条
[1]   Apathy and depressed mood in acquired brain damage: relationship to lesion localization and psychophysiological reactivity [J].
Andersson, S ;
Krogstad, JM ;
Finset, A .
PSYCHOLOGICAL MEDICINE, 1999, 29 (02) :447-456
[2]  
CARROLL BJ, 1994, CLIN CHEM, V40, P303
[3]   Robust controller design and implementation for a run-of-mine ore milling circuit [J].
Craig, IK ;
MacLeod, IM .
CONTROL ENGINEERING PRACTICE, 1996, 4 (01) :1-12
[4]  
First MB, 1997, Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II)
[5]   STRUCTURAL VALIDITY OF MADRS DURING ANTIDEPRESSANT TREATMENT [J].
GALINOWSKI, A ;
LEHERT, P .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 (03) :157-161
[6]   Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients [J].
Gerstenberg, G ;
Aoshima, T ;
Fukasawa, T ;
Yoshida, K ;
Takahashi, H ;
Higuchi, H ;
Murata, Y ;
Shimoyama, R ;
Ohkubo, T ;
Shimizu, T ;
Otani, K .
PSYCHOPHARMACOLOGY, 2003, 167 (04) :443-448
[7]  
Hammond MF, 1998, INT J GERIATR PSYCH, V13, P257, DOI 10.1002/(SICI)1099-1166(199804)13:4<257::AID-GPS773>3.0.CO
[8]  
2-U
[9]   Gender differences in severity, symptomatology and distribution of melancholia in major depression [J].
Hildebrandt, MG ;
Stage, KB ;
Kragh-Soerensen, P .
PSYCHOPATHOLOGY, 2003, 36 (04) :204-212
[10]  
KAMISHIMA K, 2003, JPN J CLIN PSYCHOPHA, V6, P341